文献速递肿瘤 PET/CT神经核医学

儿童及青少年中枢神经系统肿瘤的[18F]FET-PET检查:是否支持困难的临床决策

[18F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making?
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-01-21

回顾性分析21例儿童及青少年中枢神经系统肿瘤患者,评估[18F]FET-PET对临床决策的影响。结果显示,21例中14例的治疗管理因PET而改变,包括避免侵入性手术或活检4例、引导活检4例、改变后续治疗5例、确认诊断1例。结论认为[18F]FET-PET可能为儿童及青少年中枢神经系统肿瘤的治疗指导提供重要额外信息。

要点

  • 21例儿童及青少年中枢神经系统肿瘤患者中,14例的治疗管理因[18F]FET-PET而改变。
  • PET影响包括避免手术或活检4例、引导活检4例、改变治疗5例、确认诊断1例。
  • 作者认为[18F]FET-PET可能为儿童及青少年中枢神经系统肿瘤提供重要额外治疗指导信息。

核心结论

  • [18F]FET-PET可能为儿童及青少年中枢神经系统肿瘤患者的治疗指导提供重要额外信息。

研究设计与样本

  • 回顾性分析21例儿童及年轻成人中枢神经系统肿瘤患者,其中男性13例,初始诊断时平均年龄8.6±5.2岁,范围1-19岁。
  • 新诊断5例,经治16例;所有患者此前均已完成包括头颅磁共振成像在内的神经肿瘤学检查。
  • 所有病例的[18F]FET-PET均由多学科团队会议提出;以组织病理学(12例)和/或临床及影像随访(9例)作为参考标准。

主要发现

  • 在原有信息基础上加做[18F]FET-PET后,21例中14例的后续患者管理受到影响。
  • 影响包括避免侵入性手术或活检4例、引导活检4例、改变后续治疗5例、确认诊断1例。

临床怎么用

  • 作者认为[18F]FET-PET可能为儿童及青少年中枢神经系统肿瘤患者的治疗指导提供重要额外信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Positron emission tomography (PET) with O-(2-[18F]fluoroethyl)-L-tyrosine ([18F]FET) is a well-established tool for non-invasive assessment of adult central nervous system (CNS) tumors. However, data on its diagnostic utility and impact on clinical management in children and adolescents are limited. METHODS: Twenty-one children and young adults (13 males; mean age, 8.6 ± 5.2 years; range, 1-19 at initial diagnosis) with either newly diagnosed (n = 5) or pretreated (n = 16) CNS tumors were retrospectively analyzed. All patients had previously undergone neuro-oncological work-up including cranial magnetic resonance imaging. In all cases, [18F]FET-PET was indicated in a multidisciplinary team conference. The impact of PET imaging on clinical decision-making was assessed. Histopathology (n = 12) and/or clinical and imaging follow-up (n = 9) served as the standard of reference. RESULTS: The addition of [18F]FET-PET to the available information had an impact on further patient management in 14 out of 21 subjects, with avoidance of invasive surgery or biopsy in four patients, biopsy guidance in four patients, change of further treatment in another five patients, and confirmation of diagnosis in one patient. CONCLUSION: [18F]FET-PET may provide important additional information for treatment guidance in pediatric and adolescent patients with CNS tumors.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Kertels O, Krauß J, Monoranu CM, et al. [18F]FET-PET in children and adolescents with central nervous system tumors: does it support difficult clinical decision-making? Eur J Nucl Med Mol Imaging. 2023. PMID: 36670283. doi:10.1007/s00259-023-06114-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。